Skip to main content

Table 3 Risk factors for MACEs in patients with ACS: results of multivariate logistic regression analysis

From: Correlation of serum N-Acetylneuraminic acid with the risk and prognosis of acute coronary syndrome: a prospective cohort study

  B Sx Wald OR (95% CI) p
Neu5Ac (ng/ml) 0.003 0.001 16.351 1.003 (1.002–1.005) 0.000
Age (years) 0.011 0.011 0.936 1.011 (0.989–1.034) 0.333
Hypertension (%) 0.328 0.234 1.969 0.720 (0.456–1.139) 0.161
Smoking (%) 0.294 0.496 0.351 0.745 (0.282–1.971) 0.553
DM (%) 0.123 0.303 0.165 0.884 (0.488–1.602) 0.684
AF (%) 1.026 0.761 1.182 0.358 (0.081–1.591) 0.177
Previous stroke (%) 0.247 0.435 0.321 0.781 (0.333–1.834) 0.571
FBG (mmol/L) 0.013 0.052 0.059 1.013 (0.915–1.121) 0.807
CRP (mg/L) 0.005 0.007 0.516 1.005 (0.992–1.018) 0.473
  1. MACE Major adverse cardiovascular events, ACS Acute coronary syndrome, OR Odds ratio, CI Confidence interval, Neu5Ac N-acetylneuraminic acid, DM Diabetes mellitus, AF Atrial fibrillation, FBG Fasting blood glucose, CRP C-reactive protein